Janvier Group Biosciences

Since its origins in 1960, Janvier Group Biosciences has evolved into an essential partner in preclinical research, providing more than 3500 clients worldwide with a unique combination of models and services. We leverage the latest technologies to deliver innovative in vitro, in vivo, and custom-created models, as well as early evaluation and study services to characterize models, evaluate efficacy and tolerance, identify targets, and elucidate mechanisms of action. Janvier Group Biosciences operates internationally with a team of over 600 dedicated professionals.